April 21, 2022 Comments Off on New patent for Therapeuticsmd Inc drug IMVEXXY Posted in: Patent Added Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are sixteen patents…
The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first…
April 21, 2022 Comments Off on New tentative approval for Apotex Inc drug bendamustine hydrochloride Posted in: Tentative Approval Bendamustine hydrochloride is the generic ingredient in three branded drugs marketed by Cephalon and Eagle Pharms and is included in three NDAs. There are twenty-five patents protecting this compound. Drug…
The post New tentative approval for Apotex In…
